Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Kokoh Exa Nusantara Tbk (KOCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Kokoh Exa Nusantara Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume), while Kokoh Exa Nusantara Tbk trades at Rp100 (market cap 451.21B, 4.26M 24h volume). The key difference: Kokoh Exa Nusantara Tbk is the larger of the two by market cap, and Kokoh Exa Nusantara Tbk is more actively traded (4.26M versus 22.7K). Which is the better fit depends on your goals.
| DGNS | KOCI | |
|---|---|---|
Market Cap | 308B | 451.21B |
Volume | 22.7K | 4.26M |
Lot | 227 | 42.59K |
Turnover | 5.17M | 427.52M |
Average Price | 227.59 | 100.37 |
Value | 5.17M | 427.52M |
Indicative Equilibrium Price | 230 | 101 |
Indicative Equilibrium Volume | 110 | 822.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Kokoh Exa Nusantara Tbk
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI →
